A group of North Carolina physicians is criticizing the study used to back the U.S. Food and Drug Administration’s (FDA) decision to grant emergency use authorization for COVID-19 vaccines for 6-month to 4-year-old children.
“It was a weak and underpowered study that in no way proved the efficacy nor safety given the fact that two-thirds of the children that started the study did not complete the study for reasons that are unclear,” Dr. Kristin Strange, a pediatric member with the North Carolina Physicians for Freedom (NCPF), told The Epoch Times.
There was a negative efficacy between the first and second dose, where there was a 30 percent increase in COVID-19 cases in the vaccine group compared to the placebo, Strange said….